blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3030675

EP3030675 - URINE BIOMARKER COHORTS, GENE EXPRESSION SIGNATURES, AND METHODS OF USE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.08.2019
Database last updated on 13.11.2024
FormerThe patent has been granted
Status updated on  31.08.2018
FormerGrant of patent is intended
Status updated on  19.02.2018
FormerExamination is in progress
Status updated on  03.03.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Exosome Diagnostics, Inc.
266 Second Ave.
Suite 200
Waltham, MA 02451 / US
[2019/03]
Former [2016/24]For all designated states
Exosome Diagnostics Inc.
840 Memorial Drive
Cambridge, Massachusetts 02139 / US
Inventor(s)01 / SKOG, Johan Karl Olov
Exosome Diagnostics, Inc.
Riverside Technology Center
840 Memorial Drive
Cambridge, MA 02139 / US
02 / NOERHOLM, Mikkel
Preysingstrasse 21
82131 Gauting / DE
 [2016/37]
Former [2016/24]01 / SKOG, Johan Karl Olov
250 First Avenue
Apt. 703
Charlestown Massachusetts 02129 / US
02 / NOERHOLM, Mikkel
Preysingstrasse 21
82131 Gauting / DE
Representative(s)Cooley (UK) LLP
22 Bishopsgate
London EC2N 4BQ / GB
[N/P]
Former [2016/24]Cooley (UK) LLP
Dashwood
69 Old Broad Street
London EC2M 1QS / GB
Application number, filing date14752743.606.08.2014
[2016/24]
WO2014US49946
Priority number, dateUS201361862630P06.08.2013         Original published format: US 201361862630 P
[2016/24]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015021158
Date:12.02.2015
Language:EN
[2015/06]
Type: A1 Application with search report 
No.:EP3030675
Date:15.06.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 12.02.2015 takes the place of the publication of the European patent application.
[2016/24]
Type: B1 Patent specification 
No.:EP3030675
Date:03.10.2018
Language:EN
[2018/40]
Search report(s)International search report - published on:EP12.02.2015
ClassificationIPC:C12Q1/68
[2016/24]
CPC:
C12Q1/6886 (EP,RU,US); G16B25/10 (US); C12Q2600/112 (EP,US);
C12Q2600/118 (US); C12Q2600/158 (EP,US); C12Q2600/16 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/24]
Extension statesBA04.03.2016
ME04.03.2016
TitleGerman:URINBIOMARKERKOHORTEN, GENEXPRESSIONSSIGNATUREN UND VERFAHREN ZUR VERWENDUNG DAVON[2016/24]
English:URINE BIOMARKER COHORTS, GENE EXPRESSION SIGNATURES, AND METHODS OF USE THEREOF[2016/24]
French:COHORTES DE BIOMARQUEURS DE L'URINE, SIGNATURES D'EXPRESSION GÉNIQUE, ET PROCÉDÉS D'UTILISATION CORRESPONDANTS[2016/24]
Entry into regional phase04.03.2016National basic fee paid 
04.03.2016Designation fee(s) paid 
04.03.2016Examination fee paid 
Examination procedure04.03.2016Examination requested  [2016/24]
23.09.2016Amendment by applicant (claims and/or description)
02.03.2017Despatch of a communication from the examining division (Time limit: M06)
12.09.2017Reply to a communication from the examining division
20.02.2018Communication of intention to grant the patent
02.07.2018Fee for grant paid
02.07.2018Fee for publishing/printing paid
02.07.2018Receipt of the translation of the claim(s)
Divisional application(s)EP18198243.0  / EP3495509
Opposition(s)04.07.2019No opposition filed within time limit [2019/37]
Fees paidRenewal fee
29.08.2016Renewal fee patent year 03
28.08.2017Renewal fee patent year 04
27.08.2018Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU06.08.2014
AL03.10.2018
AT03.10.2018
CY03.10.2018
CZ03.10.2018
DK03.10.2018
EE03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
MK03.10.2018
MT03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
TR03.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
[2022/31]
Former [2021/34]HU06.08.2014
AL03.10.2018
AT03.10.2018
CY03.10.2018
CZ03.10.2018
DK03.10.2018
EE03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
MT03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
TR03.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2021/33]HU06.08.2014
AL03.10.2018
AT03.10.2018
CY03.10.2018
CZ03.10.2018
DK03.10.2018
EE03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
TR03.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2021/26]AL03.10.2018
AT03.10.2018
CY03.10.2018
CZ03.10.2018
DK03.10.2018
EE03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
TR03.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2020/25]AL03.10.2018
AT03.10.2018
CZ03.10.2018
DK03.10.2018
EE03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
MC03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
TR03.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2020/17]AL03.10.2018
AT03.10.2018
CZ03.10.2018
DK03.10.2018
EE03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
TR03.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2019/50]AL03.10.2018
AT03.10.2018
CZ03.10.2018
DK03.10.2018
EE03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SI03.10.2018
SK03.10.2018
SM03.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2019/40]AL03.10.2018
AT03.10.2018
CZ03.10.2018
DK03.10.2018
EE03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SK03.10.2018
SM03.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2019/37]AL03.10.2018
AT03.10.2018
CZ03.10.2018
DK03.10.2018
EE03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
PL03.10.2018
RO03.10.2018
RS03.10.2018
SM03.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2019/34]AL03.10.2018
AT03.10.2018
CZ03.10.2018
DK03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
PL03.10.2018
RS03.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2019/26]AL03.10.2018
AT03.10.2018
CZ03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
PL03.10.2018
RS03.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
PT03.02.2019
Former [2019/25]AT03.10.2018
CZ03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
PL03.10.2018
RS03.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
Former [2019/24]AT03.10.2018
CZ03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
PL03.10.2018
BG03.01.2019
NO03.01.2019
GR04.01.2019
IS03.02.2019
Former [2019/23]AT03.10.2018
CZ03.10.2018
ES03.10.2018
FI03.10.2018
HR03.10.2018
LT03.10.2018
LV03.10.2018
PL03.10.2018
BG03.01.2019
NO03.01.2019
IS03.02.2019
Former [2019/22]CZ03.10.2018
FI03.10.2018
LT03.10.2018
PL03.10.2018
BG03.01.2019
NO03.01.2019
IS03.02.2019
Former [2019/21]FI03.10.2018
LT03.10.2018
NO03.01.2019
IS03.02.2019
Former [2019/20]LT03.10.2018
NO03.01.2019
Cited inInternational search[I]WO2013028788  (EXOSOME DIAGNOSTICS INC [US], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.